Description
Provided are novel antibodies that specifically bind to an ORP150 polypeptide expressed of the cell surface of plasmacytoma, multiple myeloma, colorectal cancer cells, gastric cancer cells, or esophageal cancer cells. These antibodies can be used in a variety of diagnostic and therapeutic methods.
Target
HYOU1
Target Alias Names
Hypoxia Up-Regulated 1, 170 KDa Glucose-Regulated Protein, 150 KDa Oxygen-Regulated Protein, GRP-170, ORP-150, Grp170
Isotype/Mimetic
Human IgG2
Animal-Derived Biomaterials Used
None
Sequence Available
No
Original Discovery Method
Human-derived phage display
Original Discovery Information Provided On Datasheet
No
Antibody/Binder Origins
Animal-free discovery, In vitro recombinant expression